The Arab Drug Company (EGX:ADCI)

Market Cap	2.70B
Revenue (ttm)	1.03B
Net Income (ttm)	158.78M
Shares Out	12.00M
EPS (ttm)	13.23
PE Ratio	16.98
Forward PE	n/a
Dividend	4.17 (1.85%)
Ex-Dividend Date	Oct 28, 2025

Volume	49,405
Average Volume	8,185
Open	204.10
Previous Close	204.10
Day's Range	202.88 - 235.00
52-Week Range	56.00 - 249.98
Beta	0.56
RSI	61.10
Earnings Date	Nov 24, 2025

About The Arab Drug Company

The Arab Drug Company engages in the manufacture and sale of pharmaceutical products. It offers anti-infectives, central nervous system drugs, dermatological drugs, and cardiovascular drugs, as well as animal health products in powders and solutions. The company exports its products to approximately 40 countries, including China, Korea, Turkey, Kazakhstan, Iraq, Syria, Jordan, Lebanon, Libya, Sudan, Somalia, Yemen, and Morocco. The Arab Drug Company was incorporated in 1963 and is based in Cairo, Egypt.

• Industry: Pharmaceutical Preparations
• Founded: 1963
• Employees: 1,152
• Stock Exchange: Egyptian Stock Exchange
• Ticker Symbol: ADCI

Financial Performance

In 2024, The Arab Drug Company's revenue was 785.52 million, an increase of 23.95% compared to the previous year's 633.73 million. Earnings were 88.35 million, an increase of 24.21%.